Omega-3 supplementation improves pruritus in continuous ambulatory peritoneal dialysis patients: A crossover randomized pilot clinical trial

Objective: Pruritus is a prevalent skin condition in end-stage renal disease patients. Omega-3 fatty acids have been shown to reduce pruritus in hemodialysis patients. Our objective was to assess the effect of 3 g/day omega-3 supplementation on pruritus among continuous ambulatory peritoneal dialysi...

Full description

Bibliographic Details
Main Authors: Arian Pourmehdi Lahiji, Mojgan Mortazavi, Shahnaz Amani Tirani, Firouzeh Moeinzadeh, Ehsan Zarea Bidaki, Afsoon Emami Naini, Gita Faghihi, Arash Toghyani, Ziba Farajzadegan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Journal of Research in Pharmacy Practice
Subjects:
Online Access:http://www.jrpp.net/article.asp?issn=2319-9644;year=2018;volume=7;issue=4;spage=195;epage=199;aulast=Lahiji
id doaj-1da95059ef1e4bfaabd55803a5d3553e
record_format Article
spelling doaj-1da95059ef1e4bfaabd55803a5d3553e2020-11-24T21:47:42ZengWolters Kluwer Medknow PublicationsJournal of Research in Pharmacy Practice2319-96442279-042X2018-01-017419519910.4103/jrpp.JRPP_18_64Omega-3 supplementation improves pruritus in continuous ambulatory peritoneal dialysis patients: A crossover randomized pilot clinical trialArian Pourmehdi LahijiMojgan MortazaviShahnaz Amani TiraniFirouzeh MoeinzadehEhsan Zarea BidakiAfsoon Emami NainiGita FaghihiArash ToghyaniZiba FarajzadeganObjective: Pruritus is a prevalent skin condition in end-stage renal disease patients. Omega-3 fatty acids have been shown to reduce pruritus in hemodialysis patients. Our objective was to assess the effect of 3 g/day omega-3 supplementation on pruritus among continuous ambulatory peritoneal dialysis (CAPD) patients. Methods: In this two-period, two-sequence crossover randomized clinical trial, 40 eligible subjects (CAPD patients who complained of pruritus for more than 8 weeks) were randomized to 3 g of omega-3 (n = 20) or identical placebo capsules (n = 20) for 4 weeks. After a wash-out period of 6 weeks, patients were crossed over to the alternate treatment option. Pruritus intensity was assessed using the visual analog scale (VAS) at baseline, 2-and 4-weeks post-intervention in each study period. Both patients and investigators were blinded to the study protocol. Findings: No significant carry-over effect was detected. The mean pruritus score (VAS) in the omega-3 group compared with placebo group after the first (−3.02 vs. −0.48, P < 0.001) and second (−4.09 vs. −0.43, P < 0.001) intervention periods showed higher significant decrease. Conclusion: In summary, omega-3 supplementation is an effective treatment for pruritus alleviation in CAPD patients. Further studies are needed to determine the mechanisms underlying antipruritic effects of omega-3.http://www.jrpp.net/article.asp?issn=2319-9644;year=2018;volume=7;issue=4;spage=195;epage=199;aulast=LahijiContinuous ambulatory peritoneal dialysisend-stage renal diseaseOmega-3 supplementationpruritus
collection DOAJ
language English
format Article
sources DOAJ
author Arian Pourmehdi Lahiji
Mojgan Mortazavi
Shahnaz Amani Tirani
Firouzeh Moeinzadeh
Ehsan Zarea Bidaki
Afsoon Emami Naini
Gita Faghihi
Arash Toghyani
Ziba Farajzadegan
spellingShingle Arian Pourmehdi Lahiji
Mojgan Mortazavi
Shahnaz Amani Tirani
Firouzeh Moeinzadeh
Ehsan Zarea Bidaki
Afsoon Emami Naini
Gita Faghihi
Arash Toghyani
Ziba Farajzadegan
Omega-3 supplementation improves pruritus in continuous ambulatory peritoneal dialysis patients: A crossover randomized pilot clinical trial
Journal of Research in Pharmacy Practice
Continuous ambulatory peritoneal dialysis
end-stage renal disease
Omega-3 supplementation
pruritus
author_facet Arian Pourmehdi Lahiji
Mojgan Mortazavi
Shahnaz Amani Tirani
Firouzeh Moeinzadeh
Ehsan Zarea Bidaki
Afsoon Emami Naini
Gita Faghihi
Arash Toghyani
Ziba Farajzadegan
author_sort Arian Pourmehdi Lahiji
title Omega-3 supplementation improves pruritus in continuous ambulatory peritoneal dialysis patients: A crossover randomized pilot clinical trial
title_short Omega-3 supplementation improves pruritus in continuous ambulatory peritoneal dialysis patients: A crossover randomized pilot clinical trial
title_full Omega-3 supplementation improves pruritus in continuous ambulatory peritoneal dialysis patients: A crossover randomized pilot clinical trial
title_fullStr Omega-3 supplementation improves pruritus in continuous ambulatory peritoneal dialysis patients: A crossover randomized pilot clinical trial
title_full_unstemmed Omega-3 supplementation improves pruritus in continuous ambulatory peritoneal dialysis patients: A crossover randomized pilot clinical trial
title_sort omega-3 supplementation improves pruritus in continuous ambulatory peritoneal dialysis patients: a crossover randomized pilot clinical trial
publisher Wolters Kluwer Medknow Publications
series Journal of Research in Pharmacy Practice
issn 2319-9644
2279-042X
publishDate 2018-01-01
description Objective: Pruritus is a prevalent skin condition in end-stage renal disease patients. Omega-3 fatty acids have been shown to reduce pruritus in hemodialysis patients. Our objective was to assess the effect of 3 g/day omega-3 supplementation on pruritus among continuous ambulatory peritoneal dialysis (CAPD) patients. Methods: In this two-period, two-sequence crossover randomized clinical trial, 40 eligible subjects (CAPD patients who complained of pruritus for more than 8 weeks) were randomized to 3 g of omega-3 (n = 20) or identical placebo capsules (n = 20) for 4 weeks. After a wash-out period of 6 weeks, patients were crossed over to the alternate treatment option. Pruritus intensity was assessed using the visual analog scale (VAS) at baseline, 2-and 4-weeks post-intervention in each study period. Both patients and investigators were blinded to the study protocol. Findings: No significant carry-over effect was detected. The mean pruritus score (VAS) in the omega-3 group compared with placebo group after the first (−3.02 vs. −0.48, P < 0.001) and second (−4.09 vs. −0.43, P < 0.001) intervention periods showed higher significant decrease. Conclusion: In summary, omega-3 supplementation is an effective treatment for pruritus alleviation in CAPD patients. Further studies are needed to determine the mechanisms underlying antipruritic effects of omega-3.
topic Continuous ambulatory peritoneal dialysis
end-stage renal disease
Omega-3 supplementation
pruritus
url http://www.jrpp.net/article.asp?issn=2319-9644;year=2018;volume=7;issue=4;spage=195;epage=199;aulast=Lahiji
work_keys_str_mv AT arianpourmehdilahiji omega3supplementationimprovespruritusincontinuousambulatoryperitonealdialysispatientsacrossoverrandomizedpilotclinicaltrial
AT mojganmortazavi omega3supplementationimprovespruritusincontinuousambulatoryperitonealdialysispatientsacrossoverrandomizedpilotclinicaltrial
AT shahnazamanitirani omega3supplementationimprovespruritusincontinuousambulatoryperitonealdialysispatientsacrossoverrandomizedpilotclinicaltrial
AT firouzehmoeinzadeh omega3supplementationimprovespruritusincontinuousambulatoryperitonealdialysispatientsacrossoverrandomizedpilotclinicaltrial
AT ehsanzareabidaki omega3supplementationimprovespruritusincontinuousambulatoryperitonealdialysispatientsacrossoverrandomizedpilotclinicaltrial
AT afsoonemaminaini omega3supplementationimprovespruritusincontinuousambulatoryperitonealdialysispatientsacrossoverrandomizedpilotclinicaltrial
AT gitafaghihi omega3supplementationimprovespruritusincontinuousambulatoryperitonealdialysispatientsacrossoverrandomizedpilotclinicaltrial
AT arashtoghyani omega3supplementationimprovespruritusincontinuousambulatoryperitonealdialysispatientsacrossoverrandomizedpilotclinicaltrial
AT zibafarajzadegan omega3supplementationimprovespruritusincontinuousambulatoryperitonealdialysispatientsacrossoverrandomizedpilotclinicaltrial
_version_ 1725896231329202176